This page lists the SEC filings reported by ARK Investment Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | NanoString Technologies Inc | 3,822,106 | 10.1% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | VERACYTE, INC. | 7,018,770 | 12.2% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | COMPUGEN LTD | 17,672,228 | 21.3% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | ExOne Co | 4,062,980 | 21.4% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | Invitae Corp | 27,754,739 | 21.0% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | ORGANOVO HOLDINGS, INC. | 1,422,394 | 21.8% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | STRATASYS LTD. | 12,070,385 | 21.9% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | Syros Pharmaceuticals, Inc. | 11,212,506 | 24.5% | EDGAR |
| SC 13G/A | 2020-10-09 | ARK Investment Management LLC | Seres Therapeutics, Inc. | 12,293,033 | 13.8% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | CRISPR Therapeutics AG | 8,457,320 | 12.0% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | Evogene Ltd. | 4,618,845 | 14.6% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | HUYA Inc. | 7,834,947 | 11.2% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | LendingClub Corp | 7,487,851 | 10.5% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | LendingTree, Inc. | 1,347,905 | 10.3% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 19,844,780 | 11.2% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | PagerDuty, Inc. | 10,620,814 | 13.4% | EDGAR |
| SC 13G | 2020-10-09 | ARK Investment Management LLC | Proto Labs Inc | 3,094,035 | 11.6% | EDGAR |
| SC 13G/A | 2020-02-14 | ARK Investment Management LLC | ExOne Co | 2,370,763 | 14.4% | EDGAR |
| SC 13G/A | 2020-02-14 | ARK Investment Management LLC | COMPUGEN LTD | 8,975,310 | 14.5% | EDGAR |
| SC 13G/A | 2020-02-14 | ARK Investment Management LLC | Seres Therapeutics, Inc. | 7,273,840 | 10.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.